Altium Capital Management LP Ocuphire Pharma, Inc. Transaction History

Altium Capital Management LP

  • $283 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$4.24 - $6.57 $1.68 Million - $2.61 Million
-397,036 Closed
0 $0
Q1 2021

May 06, 2021
SELL
$5.7 - $13.31 $9.53 Million - $22.2 Million
-1,671,494 Reduced 80.81%
397,036 $2.31 Million
Q4 2020

Feb 16, 2021
BUY
$3.76 - $8.8 $7.78 Million - $18.2 Million
2,068,530 New
2,068,530 $13.4 Million

Others Institutions Holding OCUP

# of Institutions
43
Shares Held
2.58M
Call Options Held
14.1K
Put Options Held
800
View Full List

About Ocuphire Pharma, Inc.

OCUP Quotes by TradingView
  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email